EDGAR Filing Documents for 0001564590-17-015977

Form 8-K - Current report:

SEC Accession No. 0001564590-17-015977

Filing Date

2017-08-07

Accepted

2017-08-07 16:06:21

Documents

Period of Report

2017-08-07

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	ctmx-8k_20170630.htm	8-K	33798
2	EX-99.1	ctmx-ex991_6.htm	EX-99.1	285880
	Complete submission text file	0001564590-17-015977.txt		320812

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37587 | Film No.: 171011535
SIC: 2834 Pharmaceutical Preparations